Stay updated on Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C
Sign up to get notified when there's something new on the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page.

Latest updates to the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase 1 study of the SHP2 inhibitor BBP-398 and its combination with sotorasib, while adding references to NAV-1003 and a new revision number.SummaryDifference16%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check77 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C
Enter your email address, and we'll notify you when there's something new on the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page.